ArticleScientific reports2025
Disrupting the interaction between connexin 43 and calmodulin restores gap junction function and mitigates reperfusion arrhythmias.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Effect of ischemic preconditioning on the expression of Cx43 protein in intestinal ischemia-reperfusion injury in SD rats.Frontiers in physiology · 2026Article
- The electrophysiology of ventricular cell pairs.Pflugers Archiv : European journal of physiology · 2025Review
- History of Gap Junction Architecture and Potential Role of Calmodulin in Channel Arrays.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
In myocardial ischemia-reperfusion (I/R) injury, the downregulation of Cx43 is a critical factor influencing intercellular electrical coupling and the incidence of reperfusion arrhythmias (RA). Restoring Cx43 protein levels in cardiomyocytes has been proposed as an effective strategy to reduce RA. However, the impact of I/R on the functionality of Cx43-based gap junction (GJ) remains unclear. In this study, we utilized a 40-minute hypoxia model that did not alter Cx43 expression in cardiomyocytes but impaired GJ function. This model enabled the assessment of GJ functionality via fluorescent dye transfer without the confounding factor of reduced GJ quantity. Further investigation revealed that hypoxia/reoxygenation (H/R) upregulated calmodulin (CaM) expression and enhanced the interaction between CaM and Cx43. SP15, a peptide mimicking the CaM-binding sequence of Cx43, effectively disrupted the CaM-Cx43 interaction, mitigating H/R-induced GJ dysfunction. Additionally, in an ex vivo rat heart I/R model, SP15 improved myocardial electrophysiological parameters and reduced arrhythmia scores by interfering with CaM-Cx43 binding. These findings provide promising evidence for targeting the CaM-Cx43 interaction to improve GJ function and reduce RA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.